entertainment -WSS

entertainment

author：focus 2025-08-19 18:04:31 - browse：955

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Congress considering partial increase for doctor pay in Medicare

hotspot

WSS

National panel will explore requiring free Covid tests

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Physician groups backed by private equity giant lobby on mergers

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Scientists inch closer to single

knowledge

entertainment

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lawsuit alleges UnitedHealth Group unit illegally denied claims

23andMe had bad news about my health. I wish a person had delivered it

Physician groups backed by private equity giant lobby on mergers

23andMe had bad news about my health. I wish a person had delivered it

Wildfire pollution widens asthma inequities on Long Island

Supreme Court strikes down use of affirmative action

NIH launches clinical trials and new research office for long Covid

New air purifier tech could be key to improving indoor air quality

Tome Biosciences co

hotspot

Abbott's new heart device gets FDA advisory panel nod

New safety details link Apellis eye drug to rare cases of blindness

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Sage hopes for a blockbuster in antidepressant now before FDA

Mitch McConnell episode has important public health takeaway

Breakthrough Alzheimer’s drugs are inaccessible in rural states

hotspot

hotspot

Wikipedia

entertainment